Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Abilita Bio, Inc.

Abilita Bio, Inc.

Abilita Bio, Inc. is a method for creating GPCR-targeting antibodies founded in 2014 by Mauro Mileni.

OverviewStructured DataIssuesContributorsActivity
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Abilita Bio, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo